X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-28 | LCTC | Lifeloc Technologies, Inc | Heim Michelle | Controller | S - Sale+OE | $3.80 | -1,500 | 0 | -100% | -$5,700 | |||||
2025-04-29 | AVTR | Avantor, Inc. | Massaro Joseph R | Dir | P - Purchase | $12.30 | +8,100 | 35,038 | +30% | +$99,630 | ||||||
2025-04-28 | AVTR | Avantor, Inc. | Summe Gregory L | Dir | P - Purchase | $12.50 | +25,000 | 66,011 | +61% | +$312,500 | ||||||
2025-04-28 | AVTR | Avantor, Inc. | Kang Lan | Dir | P - Purchase | $12.57 | +5,000 | 35,215 | +17% | +$62,850 | ||||||
2025-04-28 | AVTR | Avantor, Inc. | Peacock Jonathan M | Dir | P - Purchase | $12.81 | +8,091 | 202,715 | +4% | +$103,646 | ||||||
| D | 2025-04-18 | SCND | Scientific Industries Inc | Bleichroeder LP | 10% | P - Purchase | $1.00 | +250,000 | 1,453,351 | +21% | +$250,000 | |||||
2025-02-28 | LCTC | Lifeloc Technologies, Inc | Kornelsen Vern D | CFO | P - Purchase | $3.80 | +12,250 | 2,134,245 | +1% | +$46,550 | ||||||
| AD | 2025-02-28 | LCTC | Lifeloc Technologies, Inc | Siecke Donald E. | Dir | P - Purchase | $3.80 | +16,000 | 555,352 | +3% | +$60,800 | |||||
2019-10-02 | LCTC | Lifeloc Technologies, Inc | Siecke Donald E. | Dir | P - Purchase | $1.57 | +9,347 | 460,295 | +2% | +$14,675 | ||||||
| D | 2025-04-04 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $0.65 | -25,343 | 191,374 | -12% | -$16,473 | |||||
| D | 2025-04-04 | AXDX | Accelerate Diagnostics, Inc | Mertz Larry Michael | CTO | S - Sale+OE | $0.65 | -1,523 | 84,803 | -2% | -$990 | |||||
2025-04-02 | PRPO | Precipio, Inc. | Sabet Ahmed Zaki | COO | P - Purchase | $6.00 | +79 | 939 | +9% | +$474 | ||||||
| D | 2025-04-01 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $0.71 | -6,816 | 65,328 | -9% | -$4,839 | |||||
2025-03-31 | A | Agilent Technologies, Inc. | Podolsky Daniel K | Dir | S - Sale | $116.46 | -1,819 | 35,737 | -5% | -$211,844 | ||||||
| M | 2025-03-19 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $1.00 | +77,233 | 17,236,232 | 0% | +$76,918 | |||||
| D | 2025-03-14 | BIOBI | Bio-Rad Laboratories, Inc. | Crowley Michael | EVP, GBL Commercial Operations | S - Sale+OE | $247.06 | -3,000 | 8,171 | -27% | -$741,184 | |||||
2025-03-17 | A | Agilent Technologies, Inc. | Gonsalves Rodney | VP, Corporate Controller | S - Sale | $121.98 | -1,908 | 21,826 | -8% | -$232,691 | ||||||
2025-03-10 | BRKR | Bruker Corp | Bures Thomas | Chief Accounting Officer | P - Purchase | $47.40 | +500 | 3,472 | +17% | +$23,698 | ||||||
2025-03-06 | A | Agilent Technologies, Inc. | Rataj Sue H. | Dir | S - Sale | $126.38 | -6,971 | 19,640 | -26% | -$881,009 | ||||||
2025-03-03 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.41 | -12,497 | 2,225,357 | -1% | -$17,583 | ||||||
2025-03-03 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $1.41 | -6,486 | 1,497,695 | 0% | -$9,126 | ||||||
2025-03-03 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $1.41 | -2,973 | 184,619 | -2% | -$4,183 | ||||||
2025-02-28 | LCLC | Lifeloc Technologies, Inc | Edco Partners Lllp | 10% | P - Purchase | $3.80 | +34,800 | 2,100,119 | +2% | +$132,240 | ||||||
2025-02-28 | LCTC | Lifeloc Technologies, Inc | Kashenberg Adam W. | Dir | P - Purchase | $3.80 | +1,000 | 1,000 | New | +$3,800 | ||||||
2025-02-28 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.07 | +4,820,959 | 19,490,326 | +33% | +$5,134,321 | ||||||
| D | 2025-02-28 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale+OE | $10.63 | -7,942 | 1,158,257 | -1% | -$84,393 | |||||
| M | 2025-02-26 | AVTR | Avantor, Inc. | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $17.44 | -4,532 | 86,605 | -5% | -$79,036 | |||||
| M | 2025-02-26 | AVTR | Avantor, Inc. | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $17.44 | -5,940 | 39,571 | -13% | -$103,581 | |||||
| D | 2025-02-26 | AXDX | Accelerate Diagnostics, Inc | Patience David | CFO | S - Sale+OE | $1.09 | -535 | 52,144 | -1% | -$583 | |||||
2025-02-24 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $11.07 | -4,573 | 335,324 | -1% | -$50,603 | ||||||
2025-02-24 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $11.07 | -5,092 | 1,116,199 | 0% | -$56,346 | ||||||
| D | 2025-02-24 | MTD | Mettler Toledo International Inc/ | Magloth Christian | Head of HR | S - Sale+OE | $1,313.69 | -790 | 734 | -52% | -$1,037,815 | |||||
2025-02-21 | TXG | 10X Genomics, Inc. | Mateo Alan | Dir | P - Purchase | $11.14 | +40,000 | 61,691 | +184% | +$445,572 | ||||||
2025-02-18 | PACB | Pacific Biosciences of California, Inc. | Farmer Michele | See Remarks | S - Sale | $1.88 | -24,349 | 187,592 | -11% | -$45,727 | ||||||
2025-02-18 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $1.88 | -100,773 | 1,496,681 | -6% | -$189,252 | ||||||
2025-02-18 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.88 | -259,909 | 2,237,854 | -10% | -$488,109 | ||||||
2025-02-18 | BRKR | Bruker Corp | Laukien Frank H | Pres, CEO, 10% | P - Purchase | $50.92 | +20,000 | 40,453,678 | 0% | +$1,018,330 | ||||||
| D | 2025-02-14 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $19.89 | -800 | 143,310 | -1% | -$15,912 | |||||
2025-02-11 | MTD | Mettler Toledo International Inc/ | De La Guerroniere Marc | Head of Eur, NA Market Orgs | S - Sale | $1,331.89 | -888 | 0 | -100% | -$1,182,719 | ||||||
| D | 2025-02-10 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,351.34 | -600 | 6 | -99% | -$810,806 | |||||
2025-02-06 | RVTY | Revvity, Inc. | McMurry-Heath Michelle | Dir | S - Sale | $119.49 | -1,970 | 3,021 | -39% | -$235,395 | ||||||
2025-02-04 | SEER | Seer, Inc. | Horn David R. | Pres, CFO | S - Sale | $2.24 | -3,550 | 476,961 | -1% | -$7,940 | ||||||
2025-02-04 | SEER | Seer, Inc. | Farokhzad Omid | CEO, CHAIR | S - Sale | $2.24 | -8,068 | 1,428,217 | -1% | -$18,044 | ||||||
| D | 2025-02-03 | AXDX | Accelerate Diagnostics, Inc | Phillips Jack | CEO | S - Sale+OE | $1.35 | -485 | 163,434 | 0% | -$655 | |||||
| D | 2025-01-30 | RVTY | Revvity, Inc. | Goldberg Joel S | Please See Remarks | S - Sale+OE | $126.73 | -15,170 | 97,109 | -14% | -$1,922,513 | |||||
2025-01-21 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $150.00 | -1,911 | 39,652 | -5% | -$286,650 | ||||||
2025-01-10 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $2.03 | -34,405 | 1,597,454 | -2% | -$69,980 | ||||||
| D | 2025-01-07 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale+OE | $116.81 | -5,492 | 19,652 | -22% | -$641,543 | |||||
| A | 2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $5.88 | -12,000 | 24,050 | -33% | -$70,506 | |||||
| A | 2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $6.10 | +15,000 | 24,050 | +166% | +$91,430 | |||||
| A | 2024-11-11 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $6.03 | -2,000 | 16,525 | -11% | -$12,056 | |||||
| D | 2024-12-16 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $20.16 | -180 | 142,203 | 0% | -$3,629 | |||||
2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $6.20 | -12,000 | 24,050 | -33% | -$74,400 | ||||||
2024-12-13 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | P - Purchase | $5.80 | +15,000 | 24,050 | +166% | +$87,000 | ||||||
| M | 2024-12-03 | RPID | Rapid Micro Biosystems, Inc. | Pei Melinda Litherland | Dir | P - Purchase | $1.02 | +20,000 | 54,300 | +58% | +$20,364 | |||||
| D | 2024-12-03 | MTD | Mettler Toledo International Inc/ | Keller Gerry | Head of Process Analytics | S - Sale+OE | $1,254.09 | -140 | 6 | -96% | -$175,573 | |||||
2024-12-03 | AXDX | Accelerate Diagnostics, Inc | Patience John | Dir | P - Purchase | $1.57 | +200,000 | 871,211 | +30% | +$314,000 | ||||||
2024-12-03 | AXDX | Accelerate Diagnostics, Inc | Schuler Jack W | Dir, 10% | S - Sale | $1.57 | -200,000 | 8,336,110 | -2% | -$314,000 | ||||||
| D | 2024-12-02 | BRKR | Bruker Corp | Packer Richard A | Dir | S - Sale+OE | $57.82 | -3,350 | 80,904 | -4% | -$193,683 | |||||
| D | 2024-12-02 | RVTY | Revvity, Inc. | Singh Prahlad R. | Please See Remarks | S - Sale+OE | $116.22 | -18,365 | 127,358 | -13% | -$2,134,366 | |||||
| M | 2024-11-26 | RPID | Rapid Micro Biosystems, Inc. | Pei Melinda Litherland | Dir | P - Purchase | $1.05 | +20,000 | 34,300 | +140% | +$20,999 | |||||
2024-11-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $13.69 | -6,693 | 1,109,291 | -1% | -$91,612 | ||||||
2024-11-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $13.69 | -5,807 | 339,897 | -2% | -$79,485 | ||||||
2024-11-18 | BRKR | Bruker Corp | Laukien Frank H | Pres, CEO, 10% | P - Purchase | $50.14 | +100,000 | 39,387,671 | 0% | +$5,014,069 | ||||||
| D | 2024-11-12 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $22.55 | -695 | 141,897 | 0% | -$15,669 | |||||
2024-11-11 | MTD | Mettler Toledo International Inc/ | Finney Elisha W | Dir | S - Sale | $1,311.75 | -76 | 240 | -24% | -$99,693 | ||||||
2024-11-11 | PRPO | Precipio, Inc. | Sandberg Richard A | Dir | S - Sale | $6.28 | -2,000 | 16,525 | -11% | -$12,558 | ||||||
2024-10-31 | SCND | Scientific Industries Inc | Moore John A | COB | P - Purchase | $0.97 | +7,000 | 479,772 | +1% | +$6,755 | ||||||
2024-10-09 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale | $121.73 | -2,154 | 19,652 | -10% | -$262,202 | ||||||
| M | 2024-10-07 | RVTY | Revvity, Inc. | Vohra Tajinder S | Please See Remarks | S - Sale | $122.34 | -4,307 | 21,806 | -16% | -$526,910 | |||||
2024-09-30 | PACB | Pacific Biosciences of California, Inc. | Kim Susan G. | See Remarks | S - Sale | $1.72 | -19,782 | 695,654 | -3% | -$34,065 | ||||||
2024-09-27 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $150.00 | -47 | 24,071 | 0% | -$7,050 | ||||||
2024-09-26 | A | Agilent Technologies, Inc. | Grau Dominique | SVP | S - Sale | $145.00 | -15,000 | 86,773 | -15% | -$2,175,000 | ||||||
| D | 2024-09-23 | NAUT | Nautilus Biotechnology, Inc. | Godwin Mary E. | SVP, Operations | S - Sale+OE | $2.87 | -47,031 | 0 | -100% | -$134,744 | |||||
| D | 2024-09-17 | NAUT | Nautilus Biotechnology, Inc. | Godwin Mary E. | SVP, Operations | S - Sale+OE | $2.85 | -35,000 | 0 | -100% | -$99,869 | |||||
| M | 2024-09-16 | OMIC | Singular Genomics Systems, Inc. | Tang Kevin | 10% | P - Purchase | $14.75 | +122,416 | 372,000 | +49% | +$1,806,220 | |||||
| D | 2024-09-15 | OMIC | Singular Genomics Systems, Inc. | Spaventa Andrew | CEO | S - Sale+OE | $12.38 | -175 | 140,685 | 0% | -$2,167 | |||||
2024-08-20 | QTRX | Quanterix Corp | Walt David R | Dir | P - Purchase | $13.29 | +47,000 | 1,487,342 | +3% | +$624,630 | ||||||
2024-09-16 | PACB | Pacific Biosciences of California, Inc. | Henry Christian O | See Remarks | S - Sale | $1.75 | -98,907 | 2,497,763 | -4% | -$172,692 | ||||||
| D | 2024-09-06 | BIOBI | Bio-Rad Laboratories, Inc. | Last Andrew J. | EVP, COO | S - Sale+OE | $329.94 | -3,000 | 7,559 | -28% | -$989,815 | |||||
| M | 2024-09-05 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $1.47 | +30,100 | 248,702 | +14% | +$44,240 | |||||
2024-09-05 | AVTR | Avantor, Inc. | Eck Steven W | SVP, Chief Accounting Officer | S - Sale | $25.06 | -3,525 | 29,544 | -11% | -$88,337 | ||||||
2024-09-03 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $4.00 | +500 | 218,602 | 0% | +$2,000 | ||||||
| D | 2024-09-04 | BIOBI | Bio-Rad Laboratories, Inc. | Barry James | EVP, Pres, LSG | S - Sale+OE | $330.50 | -623 | 147 | -81% | -$205,898 | |||||
2024-08-30 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $4.25 | +151 | 218,602 | 0% | +$642 | ||||||
2024-08-27 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.19 | +250,000 | 74,036,109 | 0% | +$546,750 | ||||||
| M | 2024-08-26 | TLIS | Talis Biomedical Corp | Leonard Braden Michael | 10% | P - Purchase | $3.90 | +14,382 | 217,951 | +7% | +$56,137 | |||||
| M | 2024-08-23 | HLTH | Cue Health Inc. | Tarsadia Capital, LLC | 10% | S - Sale | $0.00 | -18,302,244 | 3,613,413 | -84% | -$1,068 | |||||
| M | 2024-08-22 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.06 | +750,000 | 127,411,930 | +1% | +$1,546,237 | |||||
2024-08-22 | TXG | 10X Genomics, Inc. | Saxonov Serge | CEO | S - Sale | $22.53 | -6,749 | 1,119,184 | -1% | -$152,053 | ||||||
2024-08-22 | TXG | 10X Genomics, Inc. | Hindson Benjamin J. | See Remarks | S - Sale | $22.53 | -4,351 | 345,704 | -1% | -$98,027 | ||||||
2024-08-22 | TXG | 10X Genomics, Inc. | McAnear Justin J. | Former Chief Financial Officer | S - Sale | $22.53 | -2,961 | 143,242 | -2% | -$66,710 | ||||||
2024-08-22 | A | Agilent Technologies, Inc. | McDonnell Padraig | Pres, CEO | S - Sale | $145.00 | -1,958 | 24,118 | -8% | -$283,910 | ||||||
| M | 2024-08-19 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $1.88 | +1,250,000 | 73,036,109 | +2% | +$2,351,875 | |||||
2024-08-20 | EYPT | Eyepoint Pharmaceuticals, Inc. | Dicicco Wendy F | Dir | P - Purchase | $7.79 | +2,567 | 9,967 | +35% | +$19,997 | ||||||
2024-08-21 | EYPT | Eyepoint Pharmaceuticals, Inc. | Ando Goran | Dir | P - Purchase | $7.95 | +5,000 | 13,150 | +61% | +$39,750 | ||||||
2024-08-19 | EYPT | Eyepoint Pharmaceuticals, Inc. | Zaderej Karen L. | Dir | P - Purchase | $7.98 | +12,500 | 16,500 | +313% | +$99,750 | ||||||
2024-08-19 | PACB | Pacific Biosciences of California, Inc. | Eidel Jeff | See Remarks | S - Sale | $1.59 | -26,760 | 869,938 | -3% | -$42,602 | ||||||
2024-08-16 | PACB | Pacific Biosciences of California, Inc. | Van Oene Mark | See Remarks | S - Sale | $1.66 | -38,011 | 1,630,815 | -2% | -$63,174 | ||||||
2024-08-16 | EYPT | Eyepoint Pharmaceuticals, Inc. | Lurker Nancy | Dir | P - Purchase | $7.88 | +3,173 | 224,524 | +1% | +$25,003 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |